Principles and Application of Immunotherapy in Cancer

Event Overview

Join our expert faculty for this exclusive interactive teleconference and Webcast at your practice on the increasing role of immunotherapy for patients with melanoma or lung cancer. Topics will include tumor–immune system interaction, therapeutic strategies to enhance the immune response, current clinical efficacy and safety experience with immunotherapy, and key ongoing clinical trials in either melanoma or lung cancer.

Don’t miss this opportunity to host a 1-hour CME workshop via private Webcast on cancer integrating immunotherapy into the treatment of NSCLC or melanoma for your practice. Call 866.690.9902 or email registration@clinicaloptions.com.

CME Information

 
Program Overview
You are invited to attend a CME/ANCC/APCE-certified meeting reviewing the latest data and using case-based scenarios to explore the role of immunotherapy in melanoma or lung cancer.
 
Goal
The goal of this activity is to improve participants’ competence in choosing optimal immunotherapy-based treatment approaches for patients with melanoma and lung cancer.
 
Target Audience
This program is intended for physicians, registered nurses, pharmacists, physician extenders, and other healthcare professionals who form the multidisciplinary team to provide care for patients with melanoma and lung cancer.
 
Learning Objectives

At the conclusion of the activities, participants should be able to:

Melanoma Track

  • Describe the core principles of cancer immunotherapy as they relate to melanoma
  • Select optimal available patient-specific immunotherapies based on the latest clinical trial data on emerging immunotherapy agents for the management of patients with melanoma
  • Manage adverse events associated with cancer immunotherapy treatment
  • Provide accurate and appropriate counsel as part of the treatment team
  • Provide appropriate care and counsel for patients and their families

Lung Track

  • Describe the core principles of cancer immunotherapy as they relate to lung cancer
  • Identify patients with lung cancer who are appropriate candidates for an immunotherapy approach based on the latest clinical trial data
  • Manage adverse events associated with cancer immunotherapy treatment
  • Provide accurate and appropriate counsel as part of the treatment team
  • Provide appropriate care and counsel for patients and their families